Skip to main content
Neurones S.A. logo

Neurones S.A. — Investor Relations & Filings

Ticker · NRO ISIN · FR0004050250 LEI · 9695008Y07TSG8SZCG57 PA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 266 across all filing types
Latest filing 2022-08-03 Earnings Release
Country FR France
Listing PA NRO

About Neurones S.A.

https://www.neurones.net/en

Neurones S.A. is a consulting and digital services group with over 7,000 experts. The company's operations are structured into three primary business segments. The Infrastructure Services division focuses on ensuring the high availability, security, and performance of IT infrastructures, including cloud services. The Application Services segment delivers application-based projects to support clients undergoing digital transformation. The Consulting division provides advisory services in management, organization, and digital strategy, helping businesses optimize processes and adopt new technologies.

Recent filings

Filing Released Lang Actions
NEURONES : + 12,5% de croissance organique au 1er semestre 2022
Earnings Release Classification · 100% confidence The document is titled "INFORMATION PRESSE" and provides key financial highlights for the first half of 2022 ("C.A. 1er semestre 2022"). It includes revenue figures, organic growth rates, operational results, and updated full-year outlook/guidance. This structure—a brief, high-level announcement of period results before a full report—is characteristic of an Earnings Release (ER). It is not a comprehensive report (like 10-K or IR), nor is it a transcript (CT) or a presentation (IP). Given its focus on immediate results and outlook update, ER is the most appropriate classification. H1 2022
2022-08-03 French
NEURONES - Descriptif du programme de rachat d'actions
AGM Information Classification · 99% confidence The document is titled "DESCRIPTIF DU PROGRAMME DE RACHAT D'ACTIONS" (Description of the Share Buyback Program) and details the authorization, modalities, and objectives for NEURONES to repurchase its own shares, as approved by the Shareholders' General Meeting on June 2, 2022. It explicitly mentions the legal basis (Article 241-2 of the AMF General Regulation) and outlines the maximum price, maximum amount, and authorized objectives (cancellation, hedging, market animation, external growth). This content directly relates to the company's decision and plan regarding the repurchase of its own shares, which corresponds precisely to the definition of 'Transaction in Own Shares' (POS).
2022-06-02 French
NEURONES : Mise à disposition des informations relatives à l’Assemblée Générale Mixte du 2 juin 2022
AGM Information Classification · 98% confidence The document is explicitly titled 'Modalités de mise à disposition ou de consultation des informations relatives à l'Assemblée Générale Mixte du 2 juin 2022' (Procedures for making available or consulting information relating to the Combined General Meeting of June 2, 2022). It details where and when documents for the upcoming AGM can be accessed by shareholders. This content directly relates to the preparation and information dissemination for an Annual General Meeting. Therefore, the appropriate classification is AGM Information (AGM-R). The document length (2209 chars) is short, but its primary purpose is to announce the *availability* of AGM materials, which aligns perfectly with the AGM-R definition, rather than being a general 'Report Publication Announcement' (RPA) for a financial report.
2022-05-12 French
NEURONES : + 12,2% de croissance organique au 1er trimestre 2022
Earnings Release Classification · 98% confidence The document is titled "INFORMATION PRESSE" (Press Information) and explicitly states the reporting period as "C.A. 1er trimestre 2022" (First Quarter 2022 Revenue). It provides key financial highlights (revenue growth, operating margin) and future outlook for the full year 2022. This structure—a brief, high-level announcement of period results—is characteristic of an Earnings Release (ER), which typically precedes the more comprehensive Interim Report (IR). Since it focuses on the initial announcement of quarterly results, ER is the most appropriate classification. Q1 2022
2022-05-11 French
Neurones: Organic growth up 12.2% in 1st quarter 2022
Earnings Release Classification · 99% confidence The document explicitly states it is 'PRESS INFORMATION' regarding '1st quarter 2022 revenues' and provides key financial highlights such as organic growth, revenues, and operating profit for Q1 2022, along with an outlook for the full year 2022. This structure—a brief announcement of period-specific financial results—perfectly matches the definition of an Earnings Release (ER). It is not a comprehensive report (like IR or 10-K) nor a transcript (CT). Q1 2022
2022-05-11 English
DEU NEURONES 2021
Annual Report Classification · 100% confidence The document is titled "RAPPORT ANNUEL 2021" which translates to "Annual Report 2021" in English. It contains detailed sections about the company's activities, business segments, social responsibility, key figures, strategy, and other comprehensive information typical of an annual report. The length of the document is substantial (15,000 characters), indicating it is the full report rather than a brief announcement or summary. There is no indication that this is merely a publication announcement or a certification. The content includes financial figures, business overview, and strategic information consistent with an official yearly report covering company activity and full financial performance. Therefore, the document fits the definition of an Annual Report (10-K). FY 2021
2022-04-22 French

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.